the staff of the Ridgewood blog
Summit NJ, Johnson & Johnson spun off its Kenvue consumer brands division on Thursday, raising the most cash from an initial public offering (IPO) in more than a year. Johnson & Johnson said it sold 172.8 million shares(opens in new tab) at $22 a pop in Kenvue, giving the company whose brands include Band-Aid, Tylenol and Listerine a valuation of roughly $40 billion.
